At $84,000 Gilead Hepatitis C Drug Sets Off Payer Revolt - Bloomberg
▻http://www.bloomberg.com/news/2014-01-27/at-84-000-gilead-hepatitis-c-drug-sets-off-payer-revolt.html
As Gilead Sciences Inc. (GILD) touted its $1,000-a-pill hepatitis C cure to investors in a hotel ballroom in San Francisco, a group of about 20 protesters milled outside. “Gilead=Greed,” one sign read.
(...) worries that insurers will see Gilead’s price and force patients to try a less effective, older and cheaper therapy first (...)
Gilead’s new drug, Sovaldi, costs $84,000 for a 12-week treatment. Such breakthrough treatments and their stratospheric price tags have “absolutely” caused insurers to reconsider covering high-priced hepatitis, diabetes and other treatments,
#hépatite #santé #pharma #médicaments #prix
